RABBIT SYNDROME -AN UNCOMMON SIDE-EFFECT OF NEUROLEPTICS
Sir, Gada (1997) while reporting case of Rabbit Syndrome describes it as first in Indian literature. But to my knowledge at least two more cases have been reported earlier. Gangadhar et al. (1981) and I myself (Jain, 1993) have reported these cases in Journals none other then the official publications of I.P.S. itself. Gangadhar et al. (1981) reported this movement disorder in his patient while he was given a high potency neuroleptic in injectable form in addition to antipsychotics he earlier received. They also noted that there was patchy disappearance of movement during stage I of NREM sleep.
My case suffered with this movement disorder when she was admitted for her manic episode and received a high potency neuroleptic in injectable form. This happened just after a week of receiving the injectable preparation. She was receiving no anticholinergic medication as no E.P.S. was obvious.
This case differed from previously reported cases in two ways-(i) she was suffering from bipolar affective disorder while earlier reported cases were schizophrenics; (ii) the duration of exposure to neuroleptics was quite brief in this case while this syndrome is known to occur only after prolonged use.
RABBIT SYNDROME

Sir.
With reference to Manilal Gada's article "Rabbit syndrome-an uncommon side effect of neuroleptics" published in this journal (vol 39, No 2,1997) . I have to inform you, that while the report is interesting, author's impression that this is perhaps the first case reported from India is not correct.
We have published a case report on "Rabbit syndrome-a rare complication of long term neuroleptic medication" (Deshmukh et al., 1990) .
The syndrome is indeed rare, and I have not come across another case. D. K. DESHMUKH, 10 Mallika, Makarand Society, Mahim, 
PSYCHOTROPIC DRUG SALES IN WARANGAL
Sir.
I thank Andrade for his comments (UP, letters to editor, April, 1997) on my article about psychotropic drug sales in Warangal.
His presumptions that higher utilization of drug may reflect the prevalence of the disorder for which the drug is prescribed, higher utilization of a drug may reflect the range of
